ESMO Breast Cancer 2019: Society Profiles

Societies

ESMO - European Society for Medical Oncology

ESMO is the leading professional organisation for medical oncology. With more than 20,000 members representing oncology professionals from over 150 countries worldwide, ESMO is the society of reference for oncology education and information. ESMO is committed to offer the best care to people with cancer, through fostering integrated cancer care, supporting oncologists in their professional development, and advocating for sustainable cancer care worldwide.

EBC Council - European Breast Cancer Council

EBCCouncil-Logo

European Breast Cancer Council (EBC Council) is an association of European organisations involved in breast cancer. The three founding members of the organisation are EORTC Breast group, EUSOMA and Europa Donna.

The mission of the Association is to raise awareness and improve prevention, diagnosis, treatment and care of breast cancer patients.

ESO – European School of Oncology

ESO-Logo

The European School of Oncology (ESO) was founded in 1982, with the aim of contributing to the reduction of deaths from cancer due to late diagnosis and/or inadequate treatment. Leading oncologists from around the world played a key role in founding of the School. 

EUROPA DONNA – The European Breast Cancer Coalition

Europa-Donna-Logo

EUROPA DONNA – The European Breast Cancer Coalition is an independent non-profit organisation whose members are affiliated groups from countries throughout Europe. The Coalition works to raise awareness of breast cancer and to mobilise the support of European women in pressing for improved breast cancer education, appropriate screening, optimal treatment and increased funding for research. ED has 47-member countries.

GBG Forschungs GmbH – German Breast Group

GBG-Logo

GBG Forschungs GmbH is an independent, impartial academic research organization (ARO). Unlike contract research organisations (CRO), we do not provide research services purely on a contract basis. All study projects have to address an academic question which meets the requirements of the German Breast Group. Through our research, we aim to continually improve the treatment of breast cancer and the quality of the therapy available on a global basis.